This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Equine CD8 Monoclonal Antibody-[FITC]
Product Overview
BioVenic mouse monoclonal antibody is specific for equine CD8. It can be applied to FCM assay of equine CD8.
Specifications
Target Information
Equine CD8 is a critical co-receptor expressed on a subset of T lymphocytes, primarily involved in the immune response against intracellular pathogens and tumor cells. It functions as a co-receptor with the T cell receptor (TCR) to recognize antigens presented by major histocompatibility complex class I (MHC-I) molecules. This interaction is essential for the activation of cytotoxic T lymphocytes (CTLs), which play a significant role in eliminating infected cells and maintaining immune surveillance. In horses, CD8+ T cells are crucial for defense against viral infections such as equine herpesvirus type 1, where they contribute to the clearance of the virus through the production of interferon-gamma and cytotoxic activity.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.